Where is JW Therapeutics headquartered?

JW Therapeutics is located in Shanghai, shanghai municipality.

Who invested in JW Therapeutics?

JW Therapeutics has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has JW Therapeutics raised to date?

JW Therapeutics has raised ____.

When was the last funding round for JW Therapeutics?

JW Therapeutics closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

jwtherapeutics.com

JW Therapeutics

JW Therapeutics is a biopharmaceutical company that develops and commercializes cell-based immunotherapies for the treatment of cancer.

Business Model:

Revenue: $0

Employees: 201-500

Geographic Data

Address: 666 Haike Road

City: Shanghai

State: shanghai municipality

Zip: 201210

Country: CN

Financial Info

Stage:

series b

Raised Last:

$100M

Raised Total:

$190M

Social

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

JW Therapeutics is a biopharmaceutical company that develops and commercializes cell-based immunotherapies for the treatment of cancer.

Contact Phone:

Contact Email:

IPO Details

JW Therapeutics went public on 11/4/2020 on the Hong Kong Stock Exchange

Listed Exchange:
Hong Kong Stock Exchange

IPO Date:
11/4/2020

IPO Valuation:
$1B

Ticker Symbol:
2126

Amount Raised:
$300M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
3/2018	Series A		$0	Sequoia Capital China Temasek Holdings YuanMing Capital Juno Therapeutics WuXi AppTec Oriza Seed Capital (Oriza Yuandian) Kington Capital AVICT Global Holdings Sequoia Capital China Temasek Holdings YuanMing Capital Juno Therapeutics WuXi AppTec Oriza Seed Capital (Oriza Yuandian) Kington Capital AVICT Global Holdings
6/2020	Series B		$0	WuXi AppTec ARCH Venture Partners Loyal Valley Capital CPE Temasek Holdings Juno Therapeutics Mirae Asset Global Investments CR-CP Life Science Fund Sequoia Capital China Oriza Holdings CPE Mirae Asset Global Investments WuXi AppTec ARCH Venture Partners Loyal Valley Capital CPE Temasek Holdings Juno Therapeutics Mirae Asset Global Investments CR-CP Life Science Fund Sequoia Capital China Oriza Holdings CPE Mirae Asset Global Investments
2/2018	Venture Round	1	-	Loyal Valley Capital Loyal Valley Capital
11/2020	IPO		$300M
6/2020	Series B	10	$100M	Mirae Asset Oriza Holdings Loyal Valley Capital Temasek Sequoia Capital China ARCH Venture Partners Juno Therapeutics WuXi AppTec ARCH Venture Partners Loyal Valley Capital CPE Temasek Holdings Juno Therapeutics Mirae Asset Global Investments CR-CP Life Science Fund Sequoia Capital China Oriza Holdings WuXi AppTec CPE Mirae Asset Global Investments
3/2018	Series A	8	$90M	Temasek Sequoia WuXi AppTec Juno Therapeutics Sequoia Capital China Temasek Holdings YuanMing Capital
2/2018	Venture Round	1	-

Acquisitions

Announced Date	Name	Price
7/2020	Syracuse Biopharma

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details